Venus Remedies Receives Market Authorisations for two cancer drugs

Venus Remedies Ltd, a leading pharmaceutical company, announced that it has obtained approvals to market two important oncology medications (carboplatin and bortezomib) in Morocco and the Philippines. "These approvals are pivotal in our...

Fostering a Quality Culture in the Pharmaceutical Industry

CDSCO, in partnership with IDMA and the Drugs Control Administration of Dadra & Nagar Haveli and Daman & Diu, held a "One Day Workshop on Quality Culture" during which Dr. S. Eswara Reddy, Joint Drugs Controller (India), CDSCO, shared his views on...

Antengene Bags Thailand FDA Approval To commercialize Xpovio

Antengene Corporation Limited, a top creative, internationally-operating biopharmaceutical company focused on finding, creating, and selling top-of-the-line medications for cancer, revealed that the Thailand Food and Drug Administration has given...

Cabinet Nods Health Coverage For Senior Citizens Aged 70 years & above

The Prime Minister Narendra Modi-led Union Cabinet has given the green light for health coverage for all elderly citizens aged 70 and above, regardless of income, as part of the main scheme Ayushman Bharat Pradhan Mantri Jan Arogya Yojana...

EMA Nods pre-filled syringe For administration of Eylea 8 mg in EU

The pre-filled syringe for administering Eylea 8 mg (114.3 mg/ml solution for injection) has been authorized by the European Medicines Agency (EMA) for use in the European Union. The recently introduced pre-filled syringe OcuClick offers...

Strides Pharma receives US FDA Nod for theophylline ER tablets

The FDA has approved Strides Pharma Global, Singapore's generic theophylline extended-release tablets, 300 mg and 450 mg.The product is identical in bioavailability and therapeutic effects to the Reference Listed Drug (RLD), THEO-DUR, from...

US FDA Nods BlueRock's IND Application For iPSC-derived Cell Therapy

BlueRock Therapeutics LP, a company developing cell therapy in clinical stage and a subsidiary of Bayer AG, announced the FDA's approval of its IND application for OpCT-001, a treatment for primary photoreceptor diseases. BlueRock Therapeutics LP...

US FDA Nods SmartAdjust technology for Individuals with type 2 Diabetes

The FDA broadened the uses of Insulet SmartAdjust, a technology for diabetes management, to include type 2 diabetes in adults over 18 years old, in addition to type 1 diabetes in individuals aged two and older. Software that automatically adjusts...

Granules Receives USFDA Nod for Generic Glycopyrrolate Oral Solution

Granules India's subsidiary, Granules Pharmaceuticals Inc, has been granted approval by the US health regulator for a generic Glycopyrrolate oral solution meant for pediatric patients with neurological conditions linked to drooling. Granules India...

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.